Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis

Cytokine

Volumn 9, Issue 6, 1997, Pages 437-446

  Zhu, Xiao Hong ^a   Zellweger, René ^a,b   Wichmann, Matthias W ^a   Ayala, Alfred ^a   Chaudry, Irshad H ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cytokine gene expression; Kupffer cells; Metoclopramide; Peritoneal macrophages; Prolactin; Sepsis; Splenic macrophages

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; METOCLOPRAMIDE; PROLACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HORMONAL REGULATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS;

ANIMALIA;

EID: 0031172628     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0186     Document Type: Article

References (51)

1. 1. Baue AE (1975) Multiple, progressive, or sequential systems failure: a syndrome of the 1970s. Arch Surg 110:779-781.
2. 2. Cerra FB (1989) Multiple organ failure syndrome. In Bihari DJ, Cerra FB (eds) Multiple Organ Failure, Society of Critical Care Med., Fullerton, CA, pp. 1-24.
3. 3. Faist E, Baue AE, Dittmer H (1983) Multiple organ failure in polytrauma patients. J Trauma 23:775-787.
4. 4. Deitch EA (1990) Multiple organ failure: Summary and overview. In Deitch EA (ed.) Multiple Organ Failure, Thieme Medical Publishers, New York, pp. 285-299.
5. 5. Inoue S, Wirman JA, Alexander JW, Trocki O, Cardell RR (1988) Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 44:479-492.
6. 6. Beutler B, Cerami A (1989) The biology of cachectin/ TNF - a primary mediator of the host response. Ann Rev Immunol 7:625-655.
7. 7. Rosenstreich DL, Vogel SN, Jacques A, Wahl LM, Scher I, Mergenhagen SE (1978) Differential endotoxin sensitivity of lymphocytes and macrophages from mice with an X-linked defect in B cell maturation. J Immunol 121:685-690.
8. 8. Vogel SN, Hansen CT, Rosenstreich DL (1979) Characterization of a congenitally LPS-resistant, athymic mouse strain. J Immunol 122:619-622.
9. 9. Schirmer WJ, Schirmer JM, Fry DE (1989) Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Arch Surg 124:445-448.
10. 10. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, III, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
11. 11. Tracey KJ, Lowry SF, Fahey TJ,III, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H, Cerami A, Shires GT (1987) Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 164:415-422.
12. 12. Sheppard BC, Fraker DL, Norton JA (1989) Prevention and treatment of endotoxin and sepsis with recombinant human tumor necrosis factor. Surgery 106:156-162.
13. 13. Alexander HR, Langstein HN, Doherty GM, Jensen JC, Norton JA (1990) Human recombinant tumor necrosis factor (hr TNF) protection against endotoxin-induced shock and lethality in the rat. Surg Forum 41:103-105.
14. 14. van der Meer JW, Barza M, Wolff SM, Dinarello CA (1988) A low dose of recombinant interleukin-1 protects granulocytopenic mice from lethal gram-negative infection. Proc Natl Acad Sci USA 85:1620-1623.
15. 15. Ayala A, Kisala JM, Felt JA, Perrin MM, Chaudry IH (1992) Does endotoxin tolerance prevent the release of inflammatory monokines (IL-1, IL-6, or TNF) during sepsis? Arch Surg 127:191-197.
16. 16. Ayala A, Perrin MM, Kisala J, Ertel W, Chaudry IH (1990) Sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Surg Forum 41:117-119.
17. 17. Besedovsky H, Sorkin E (1977) Network of immune-neuroendocrine interactions. Clin Exp Immunol 27:1-12.
18. 18. Spangelo BL, Hall NRS, Ross PC, Goldstein AL (1987) Stimulation of in vivo antibody production and Con-A induced mouse spleen mitogenesis by prolactin. Immunopharmacology 14:11-20.
19. 19. Gala RR (1991) Prolactin and growth hormone in the regulation of the immune system (Minireview). Proc Soc Exp Biol Med 198:513-527.
20. 20. Berczi I, Nagy E, Kovacs K, Horvath E (1981) Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol 98:506-513.
21. 21. Berczi I, Nagy E (1991) Effects of hypophysectomy on immune function. In Ader R, Felten D1, Cohen N (ed.), Psychoneuroimmunology, Academic Press, New York, pp. 339.
22. 22. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K (1983) Immunomodulation by bromocriptine. Immunopharmacology 6:231-243.
23. 23. Ehrenkranz RA, Ackerman BA (1986) Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics 78:614-620.
24. 24. Guyton AC (1991) Pregnancy and lactation. In Wonsiewicz MJ (ed.) Textbook of Medical Physiology, Eighth Edition, W.B. Saunders, Philadelphia, pp. 926.
25. 25. Wong GC, Clark SC (1988) Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9:137-139.
26. 26. Border J (1988) Hypothesis: sepsis, multiple systems organ failure, and the macrophage. Arch Surg 123:285-286.
27. 27. Wallach D, Holtmann H, Engelmann H, Nophan Y (1988) Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. J Immunol 140:2994-2999.
28. 28. Rook GAW, Hernandez-Pando R, Lightman SL (1994) Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15:301-303.
29. 29. Parrott RF, Goode JA (1993) Central effects of naloxone and selected opioid agonists on cortisol and prolactin secretion in non-stressed sheep. Gen Pharmacol 24:101-103.
30. 30. Bateman A, Singh A, Kral T, Solomon S (1989) The immune-hypothalamic-pituitary-adrenal axis. Endocrin Rev 10:92-112.
31. 31. Cohen P, Guillevin L (1993) Corticosteroids. Principles and rules of their use, posology. Rev Prat 43:247-250.
32. 32. Holaday JW, Kenner JR, Smith PF, Bryant HU, Berton EW (1993) Neuroendocrine regulation of immune function. In Faist E, Meakins J, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis, Springer-Verlag, Berlin Heidelberg, p. 59-65.
33. 33. Berczi I, Nagy E (1986) Prolactin and other lactogenic hormones. In Berczi I (ed.) Pituitary Function and Immunology, CRC Press, Boca Raton, FL, pp. 168.
34. 34. Brouwers JRBJ, Assies J, Wiersinga WM, Huizing G, Tytgat GN (1980) Plasma prolactin levels after acute and subchronic oral administration of domperidone and of metoclopramide: A cross-over study in healthy volunters. Clin Endocrinol 12:435-440.
35. 35. Bernton EW, Meltzer MS, Holaday JW (1988) Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401-404.
36. 36. Zuckerman SH, Evans GF, Snyder YM, Roeder WD (1989) Endotoxin-macrophage interaction: post-translation regulation of tumor necrosis factor expression. J Immunol 143:1223-1227.
37. 37. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH (1991) The complex pattern of cytokines in sepsis - Association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148.
38. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384.
39. 39. Gala RR, Shevach EM (1993) Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623.
40. 40. Gagnerault M-C, Touraine P, Savino W, Kelly PA, Dardenne M (1993) Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 150:5673-5681.
41. 41. Martin CA, Dorf ME (1991) Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 135:245-258.
42. 42. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB (1987) Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84:6020-6024.
43. 43. Zhu X-L, Zellweger R, Zhu X-H, Ayala A, Chaudry IH (1995) Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine 7:8-14.
44. 44. Zhu X-H, Zellweger R, Ayala A, Chaudry IH (1996) Prolactin inhibits the increased cytokine gene expression in Kupffer cells following haemorrhage. Cytokine 8:134-140.
45. 45. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335.
46. 46. Stephan RN, Kupper TS, Geha AS, Baue AS, Chaudry IH (1987) Haemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 122:62-68.
47. 47. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH (1991) Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity: involvement of cell-associated TNF and reactive nitrogen. J Immunol 147:4147-4154.
48. 48. Rana MW, Ayala A, Dean RE, Chaudry IH (1990) Decreased Fc receptor expression on macrophages following simple haemorrhage as observed by scanning immuno electron microscopy. J Leukocyte Biol 48:512-518.
49. 49. Salmeron G, Lipsky PE (1983) Immunosuppressive potential of antimalarials. Am J Med 75:19-24.
50. 50. Chirgwin JM, Przybyla AE, MocDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
51. 51. Jonas E, Sargent TD, Dawid IB (1985) Epidermal keratin gene expressed in embryos of xenopus laevis. Proc Natl Acad Sci USA 82:5413-5417.